[1] HARPER M, BOYCE J D, ADLER B. Pasteurella multocida pathogenesis:125 years after Pasteur[J]. FEMS Microbiol Lett, 2006, 265(1):1-10.
[2] WILSON B A, HO M. Pasteurella multocida:from zoonosis to cellular microbiology[J]. Clin Microbiol Rev, 2013, 26(3):631-655.
[3] AKTORIES K, ORTH J H C, ORTH B. Pasteurella Multocida:Molecular Biology, Toxins and Infection[M]. Berlin, Heidelberg:Springer, 2012:39-51.
[4] HARPER M, COX A D, ADLER B,et al. Pasteurella multocida lipopolysaccharide:the long and the short of it[J]. Vet Microbiol, 2011, 153(1-2):109-115.
[5] ADLER, BULACH D, CHUNG J, et al. Candidate vaccine antigens and genes in Pasteurella multocide[J]. J Biotechnol, 1999, 73(2-3):83.
[6] PATTISON M, MCMULLIN P F, BRADBURY J M, et al. Poultry diseases[M]. Amsterdam, The Netherlands:Elsevier, 2008:149-154.
[7] DZIVA F, MUHAIRWA A P, BISGAARD M, et al. Diagnostic and typing options for investigating diseases associated with Pasteurella multocida[J]. Vet Microbiol, 2008, 128(1-2):1-22.
[8] HOPKINS B A, OLSON L R D.Comparison of live avirulent PM-1 and CU fowl cholera vaccines in turkeys[J]. Avian Dis, 1997, 41(2):317-325.
[9] BIERER B W, DERIEUX W T.Immunologic response of turkeys to an avirulent Pasteurella multocida vaccine in the drinking water.:2.
Duration of immunity[J]. Poult Sci, 1972, 51(4):1402-1408.
[10] HERTMAN I, MARKENSON J, MICHAEL A,et al. Attenuated live fowl cholera vaccine I. Development of vaccine strain M3G of Pasteurella multocida[J]. Avian Dis, 1979, 23(4):863-869.
[11] HOPKINS B A,HUANG T H M, OLSON L D. Differentiating turkey postvaccination isolants of Pasteurella multocida using arbitrarily primed polymerase chain reaction[J]. Avian Dise, 1998, 42(2):265-274.
[12] UZZAU S, MAROGNA G, LEORI G S,et al. Virulence attenuation and live vaccine potential of aroA, crp cdt cya, and plasmid-cured mutants of Salmonella enterica serovar Abortusovis in mice and sheep[J]. Infect Immun, 2005, 73(7):4302-4308.
[13] HOMCHAMPA P, STRUGNELL R A, ADLER B.Cross protective immunity conferred by a marker-free aroA mutant of Pasteurella multocida[J]. Vaccine, 1997, 15(2):203-208.
[14] SCOTT P C, MARKHAM J F, WHITHEAR K G.Safety and efficacy of two live Pasteurella multocida aro-A mutant vaccines in chickens[J]. Avian Dise, 1999, 43(1):83-88.
[15] CHUNG J Y, WILKIE I, BOYCE J D,et al. Role of capsule in the pathogenesis of fowl cholera caused by Pasteurella multocida serogroup A[J]. Infect Immun, 2001, 69(4):2487-2492.
[16] CHUNG J Y, WILKIE I, BOYCE J D,et al. Vaccination against fowl cholera with acapsular Pasteurella multocida A:1[J]. Vaccine, 2005, 23(21):2751-2755.
[17] 王林柏,孙久鹤,郭东春,等. 国内部分地区多杀性巴氏杆菌荚膜血清型和基因型的研究[J]. 中国预防兽医学报, 2016, 38(2):116-119.
WANG L B, SUN J H, GUO D C, et al. Identification of capsule serotype and genotype ofPasteurella multocida in some areas of China[J]. Chinese Journal of Preventive Veterinary Medicine, 2016, 38(2):116-119. (in Chinese)
[18] 吾鲁木汗·那孜尔别克,张宇凤,龚凤娟,等. 禽多杀性巴氏杆菌C48-3株hexABC基因缺失株的构建及其生物学特性分析[J]. 中国预防兽医学报, 2012, 34(8):597-601.
WULUMUHAN·NAZIERBIEKE, ZHANG Y F, GONG F J, et al. Construction and characterization of the hexABC gene deletion mutant of avian Pasteurella multocida C48-3[J]. Chinese Journal of Preventive Veterinary Medicine, 2012, 34(8):597-601. (in Chinese)
[19] HARPER M, COX A, ST MICHAEL F,et al. Decoration of Pasteurella multocida lipopolysaccharide with phosphocholine is important for virulence[J]. J Bacteriol, 2007, 189(20):7384-7391.
[20] BOYCE J D, HARPER M, ST MICHAEL F, et al. Identification of novel glycosyltransferases required for assembly of the Pasteurella multocida A:1 lipopolysaccharide and their involvement in virulence[J]. Infect Immun, 2009, 77(4):1532-1542.
[21] HARPER M, JOHN M, EDMUNDS M,et al. Protective efficacy afforded by live Pasteurella multocida vaccines in chickens is independent of lipopolysaccharide outer core structure[J]. Vaccine, 2016, 34(14):1696-1703.
[22] GOSSET G, ZHANG Z G, NAYYAR S, et al. Transcriptome analysis of Crp-dependent catabolite control of gene expression in Escherichia coli[J]. J Bacteriol, 2004, 186(11):3516-3524.
[23] CHARLES R C, HARRIS J B, CHASE M R, et al. Comparative proteomic analysis of the PhoP regulon in Salmonella enterica serovar Typhi versus Typhimurium[J]. PLoS One, 2009, 4(9):e6994.
[24] XIAO K P, LIU Q, LIU X Y, et al. Identification of the avian Pasteurella multocida phoP gene and evaluation of the effects of phoP deletion on virulence and immunogenicity[J]. Int J Mol Sci, 2015, 17(1):12.
[25] ZHAO X X, LIU Q, XIAO K P, et al. Identification of the crp gene in avian Pasteurella multocida and evaluation of the effects of crp deletion on its phenotype, virulence and immunogenicity[J]. BMC Microbiol, 2016, 16(1):125.
[26] STEEN J A, STEEN J A, HARRISON P, et al. Fis is essential for capsule production in Pasteurella multocida and regulates expression of other important virulence factors[J]. PLoS Pathog, 2010, 6(2):e1000750.
[27] MÉGROZ M, KLEIFELD O, WRIGHT A, et al. The RNA-binding chaperone Hfq is an important global regulator of gene expression in Pasteurella multocida and plays a crucial role in production of a number of virulence factors, including hyaluronic acid capsule[J]. Infect Immun, 2016, 84(5):1361-1370.
[28] BORDING A, NYMARK K, SMIDT E. Field trials with a new genetically engineered vaccine for protection against progressive atrophic rhinitis in pigs[J]. Acta Vet Scand, 1994, 35(2):155-163.
[29] WU J R, SHIEN J H, SHIEH H K,et al. Protective immunity conferred by recombinant Pasteurella multocida lipoprotein E (PlpE)[J]. Vaccine, 2007, 25(21):4140-4148.
[30] HATFALUDI T, AL-HASANIK, GONG L, et al. Screening of 71 P. multocida proteins for protective efficacy in a fowl cholera infection model and characterization of the protective antigen PlpE[J]. PLoS One, 2012, 7(7):e39973.
[31] 王红勋. 禽多杀性巴氏杆菌PlpB基因克隆、表达及表达蛋白生物学特性研究[D]. 武汉:华中农业大学, 2007.
WANG H X. Cloning and expression the PlpB gene of Pasteurellla multocida and biological characterization of the expressing proteins[D]. Wuhan:Huazhong Agricultural University, 2007. (in Chinese)
[32] HATFALUDI T, AL-HASANI K, BOYCE J D, et al. Outer membrane proteins of Pasteurella multocida[J]. Vet Microbiol, 2010, 144(1-2):1-17.
[33] DABO S M, CONFER A, MONTELONGO M,et al. Vaccination with Pasteurella multocida recombinant OmpA induces strong but non-protective and deleterious Th2-type immune response in mice[J]. Vaccine, 2008, 26(34):4345-4351.
[34] LEE J, KIM Y B, KWON M.Outer membrane protein H for protective immunity against Pasteurella multocida[J]. J Microbiol, 2007, 45(2):179-184.
[35] LUO Y, GLISSON J R, JACKWOOD M W,et al. Cloning and characterization of the major outer membrane protein gene (ompH) of Pasteurella multocida X-73[J]. J Bacteriol, 1997, 179(24):7856-7864.
[36] 曹素芳,黄青云. 禽多杀性巴氏杆菌C48-1成熟外膜蛋白H重组亚单位疫苗免疫效果的研究[J]. 中国兽医科学, 2006, 36(6):464-467.
CAO S F, HUANG Q Y. Studies on immune efficacy of recombinant subunit vaccine with mature outer membrane protein H against avian Pasteurella multocida C48-1[J]. Veterinary Science in China, 2006, 36(6):464-467. (in Chinese)
[37] STHITMATEE N, NUMEE S, KAWAMOTO E,et al. Protection of chickens from fowl cholera by vaccination with recombinant adhesive protein of Pasteurella multocida[J]. Vaccine, 2008, 26(19):2398-2407.
[38] THANASARASAKULPONG A, POOLPERM P, TANGJITJAROEN W,et al. Comparison of the effect of two purification methods on the immunogenicity of recombinant outer membrane protein H of Pasteurella multocida serovar A:1[J]. Vet Med Int, 2016, 2016:2579345.
[39] VARINRAK T, POOLPERM P, SAWADA T, et al. Cross-protection conferred by immunization with an rOmpH-based intranasal fowl cholera vaccine[J]. Avian Pathol, 2017, 46(5):515-525.
[40] HERATH C, KUMAR P, SINGH M,et al. Experimental iron-inactivated Pasteurella multocida A:1 vaccine adjuvanted with bacterial DNA is safe and protects chickens from fowl cholera[J]. Vaccine, 2010, 28(11):2284-2289.
[41] ALI H A, SAWADA T, NODA K.Protectivity of an immunoaffinity-purified 39 kDa capsular protein of avian Pasteurella multocida in mice[J]. J Vet Med Sci, 2004, 66(12):1603-1604.
[42] ALI H A H, SAWADA T, HATAKEYAMA H, et al. Characterization of a 39 kDa capsular protein of avian Pasteurella multocida using monoclonal antibodies[J]. Vet Microbiol, 2004, 100(1-2):43-53.
[43] STHITMATEE N, YANO T, LAMPANG K N, et al. A 39-kDa capsular protein is a major cross-protection factor as demonstrated by protection of chickens with a live attenuated Pasteurella multocida strain of P-1059[J]. J Vet Med Sci, 2013, 75(7):923-928.
[44] 恩特马克·布拉提白,彭清忠,严芳,等. 禽多杀性巴氏杆菌粘附蛋白Cp39的交叉免疫保护作用[J]. 微生物学报, 2010, 50(3):360-366.
BORRATHYBAY E, PENG Q Z,YAN F, et al. Cross-protective effect of the Cp39 adhesive proteins against avian Pasteurella multicida in mice[J]. Acta Microbiologica Sinica, 2010, 50(3):360-366. (in Chinese)
[45] 吾鲁木汗·那孜尔别克,彭清忠,何翠,等. 禽巴氏杆菌C48-3株成熟黏附蛋白基因cpm39的克隆及序列分析[J]. 生物技术通讯, 2008, 19(1):17-19.
NAZIERBIEKE U, PENG Q Z, HE C,et al. Cloning and sequencing of a mature adhesive protein gene cpm39 of avian Pasteurella multocida C48-3[J]. Letters in Biotechnology, 2008, 19(1):17-19. (in Chinese)
[46] BORRATHYBAY E, SAWADA T, KATAOKA Y, et al. A 39 kDa protein mediates adhesion of avian Pasteurella multocida to chicken embryo fibroblast cells[J]. Vet Microbiol, 2003, 97(3-4):229-243.
[47] TATUM F M, TABATABAI L B, BRIGGS R E.Protection against fowl cholera conferred by vaccination with recombinant Pasteurella multocida filamentous hemagglutinin peptides[J]. Avian Dis, 2009, 53(2):169-174.
[48] TATUM F M, TABATABAI L B, BRIGGS R E.Cross protection against fowl cholera disease with the use of recombinant Pasteurella multocida FHAB2 peptides vaccine[J]. Avian Dis, 2012, 56(3):589-591.
[49] SELLYEI B, BÁNYAI K, MAGYAR T. Characterization of the ptfA gene of avian Pasteurella multocida strains by allele-specific polymerase chain reaction[J]. J Vet Diagn Invest, 2010, 22(4):607-610.
[50] VARGA Z, VOLOKHOV D V, STIPKOVITS L, et al. Characterization of Pasteurella multocida strains isolated from geese[J]. Vet Microbiol, 2013, 163(1-2):149-156.
[51] GONG Q, QU N, NIU M F, et al. Evaluation of immunogenicity and protective efficacy of recombinant ptfA of avian Pasteurella multocida[J]. Iran J Vet Res, 2016, 17(2):84-88.
[52] GONG Q, CHENG M, NIU M F.Out membrane protein DNA vaccines for protective immunity against virulent avian Pasteurella multocida in chickens[J]. Proc Environ Sci, 2011, 8:723-729.
[53] GONG Q, QU N, NIU M F, et al. Immune responses and protective efficacy of a novel DNA vaccine encoding outer membrane protein of avian Pasteurella multocida[J]. Vet Immunol Immunopathol, 2013, 152(3-4):317-324.
[54] OKAY S, ÖZCENGIZ E, ÖZCENGIZ G. Immune responses against chimeric DNA and protein vaccines composed of plpEN-OmpH and PlpEC-OmpH from Pasteurella multocida A:3 in mice[J]. Acta Microbiol Immunol Hung, 2012, 59(4):485-498.
[55] 曹素芳,黄青云,韩先干,等. 禽多杀性巴氏杆菌C48-1外膜蛋白H基因真核表达载体的构建[J]. 中国兽医科技, 2005, 35(2):117-120.
CAO S F, HUANG Q Y, HAN X G, et al. Construction of eukaryotic expression vector of outer membrane protein H gene of avian Pasteurella multocida C48-1[J]. Chinese Journal of Veterinary Science and Technology, 2005, 35(2):117-120. (in Chinese) |